CYTODROX (HYDROXYUREA)500MG – 100 tablet

$54.00

Each Cytodrox contains 500 mg Hydroxyurea 100 tablets. It is used to treat a type of leukemia and cancer of the head and neck and sickle cell anemia.

ATC Classification: L01XX05
Active Ingrediant: HYDROXYUREA
Generic Name: CYTODROX
Manufacturer: Cipla Limited
Strength: 500MG
Dosage Type: Capsule
Packaging Type: Foil
Contains: 100 Cap

Important update for customers in the USA:

Most of the World has stopped all packages mailing to the USA due to De Minimus Exemption.

  1. WE ARE SHIPPING TO THE USA The only or best option right now is trans shipment to the USA, we are holding India post and express mail shipments until India sets up a taxation / tariff collection system on our side which they say can take 1 month or longer.
  2. We ship normally to the UK, AUS, Japan, and most others. The situation only involves the USA.
  3. For people who have placed an order for express mail we will ship this out once India mail is open or you can contact us to make arrangements to ship through Trans Shipping and pay the tariff and shipping costs this way.
  4. We are very sorry for this, the USA policy shift came fast, without rules or regulations, and not understanding of what other countries should do.
  5. As things develop we will adjust our shipping prices and operations to best service you.
Thanks for your patience.
CYTODROX (HYDROXYUREA)500MG – 100 tablet
CYTODROX (HYDROXYUREA)500MG – 100 tablet
$54.00

Hydroxyurea Information


Pronunciation

hye droks ee yoor EE a

 

What is this drug used for?

• It is used to treat a type of leukemia.

• It is used to treat cancer of the head and neck.

• It is used to treat sickle cell anemia.

• It may be given to you for other reasons. Talk with the doctor.

Frequently reported side effects of this drug

• Hair loss

• Nausea

• Lack of appetite

• Constipation

• Diarrhea

• Weight gain

• Headache

• Mouth sores

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• Infection

• Mole changes

• Skin growths

• Severe pulmonary disorder like lung or breathing problems like difficulty breathing, shortness of breath, or a cough that is new or worse

• Bruising

• Bleeding

• Severe loss of strength and energy

• Skin ulcers

• Skin changes

• Nail changes

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

 

Medication Safety Issues

Sound-alike/look-alike issues:

Hydrea may be confused with Lyrica

Hydroxyurea may be confused with hydroxychloroquine, hydrOXYzine

High alert medication:

This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.

International issues:

Hydrea [US, Canada, and multiple international markets] may be confused with Hydra brand name for isoniazid [Japan]

 

Product Availability

Siklos 100 mg functionally scored tablets: FDA approved May 2019; anticipated availability is currently unknown. Consult the prescribing information for additional information.

 

Storage and Stability

Droxia, Hydrea: Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F). Keep bottle tightly closed.

Siklos: Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F). Keep bottle tightly closed; use split tablets within 3 months.

 

Adverse Reactions

Central nervous system: Headache, severe nervous system disease

Dermatologic: Dermal ulcer (Antonioli 2012), dermatological reaction, eczema (infants and children [Thornburg 2012]), leg ulcer (Hernández-Boluda 2011), skin depigmentation

Endocrine & metabolic: Vitamin D deficiency, weight gain

Gastrointestinal: Acute mucocutaneous toxicity (Hernández-Boluda 2011), constipation, gastric distress (infrequent [Antonioli 2012]), gastritis, nausea, oral mucosa ulcer (infrequent [Hernández-Boluda 2011])

Genitourinary: Urinary tract abnormality

Hematologic & oncologic: Anemia, bone marrow depression (recovery: within 2 weeks), hemorrhage, leukemia, leukopenia, macrocytosis (MCV >97 [Randi 2005]), neutropenia, thrombocytopenia

Infection: Bacterial infection, infection, parvovirus B19 seroconversion, viral infection

Neuromuscular & skeletal: Panniculitis (Antonioli 2012)

Renal: Renal disease

Respiratory: Asthma (infants and children [Thornburg 2012])

Miscellaneous: Fever

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Brand

Cipla

Reviews

There are no reviews yet.

Be the first to review “CYTODROX (HYDROXYUREA)500MG – 100 tablet”

Your email address will not be published. Required fields are marked *